Answer extracted from the Invest Like The Best podcast — listen to the full episode below.
Why do investors often rely on pedigree instead of technical intuition when assessing research-heavy AI companies?
Many investors making large-scale research bets on AI companies lack a grounded point of view on the business itself and instead proxy judgment to pedigree—who has invested, referral sources, the founder's background—rather than understanding the underlying technical theory and business logic. This approach is fundamentally dangerous because it substitutes intuition built on deep understanding with convenience signals that obscure real risk.
The problem runs deeper than simple due diligence shortcuts. When investors lack intuition beyond pedigree, they become vulnerable to mimetic risk: everyone makes the same bets based on the same visible signals, creating concentration without genuine differentiation of judgment. In a field as complex and as rapidly evolving as AI research, this dependency on surface-level credibility markers leaves investors exposed to systematic misjudgments about what actually works.
As explored in detail in this episode of Invest Like The Best, the competitive landscape in AI research is intensely pressurized. Investors feel the weight of global competition and the fear of missing exponential opportunities. Under that pressure, the temptation to rely on "safe" signals—backing founders from prestigious labs like OpenAI or DeepMind, following where established names have already invested—becomes almost irresistible. Yet that very safety mechanism can become the source of collective error.
Sarah — Investor at Greylock, focused on early-stage AI, biology, defense, and robotics. Sarah leads a venture fund alongside partners including Mike, Pranav, and Bella, and chose investing over entrepreneurship after recognizing her deepest motivation: understanding things thoroughly and helping extraordinary people succeed through strategic capital and network support.
Building real intuition requires time and intellectual rigor. It means reading the technical papers, understanding the mathematical foundations, grasping the computational constraints, and then reasoning about whether the business model actually captures the value that the technology creates. It means knowing why a particular lab or founder might succeed or fail, not just who they know. Sarah's investment approach reflects this standard: initial conviction is scored immediately, then systematically stress-tested through deep research.
The stakes are high. Research-heavy AI companies require sustained capital, often reaching thresholds of hundreds of millions or billions in compute spend. Mistakes at that scale are not easily recovered from. An investor without genuine technical and business intuition cannot distinguish between a visionary bet that will reshape the industry and an expensive dead-end backed by impressive credentials.
The alternative is harder but clearer: develop your own point of view. Understand the frontier not through rumor or fund rankings, but through direct engagement with the technical and strategic questions. This is why Sarah tracks roughly 250 entrepreneurs and researchers at the cutting edge of AI—a network built through sustained curiosity and real knowledge, not passive signal-following.
See also
How should venture investors balance conviction-based decision-making with seeking external validation on investment theses?
Sarah describes her process as starting with instinctive conviction on people and ideas, immediately rating them 8 or 9, then spending days to weeks validating or invalidating that initial conviction through deeper research.
What decision-making framework should investors use when evaluating AI companies in a period of rapid technological change?
Sarah emphasizes taking a very specific view of what is now possible, then determining what is valuable within what is possible, and identifying who is positioned to capture that value.